Outcomes of Elective and Non-elective Fenestrated-branched Endovascular Aortic Repair for Treatment of Thoracoabdominal Aortic Aneurysms

  • Marina Dias-Neto
  • Andrea Vacirca
  • Ying Huang
  • Aidin Baghbani-Oskouei
  • Tomasz Jakimowicz
  • Bernardo C Mendes
  • Tilo Kolbel
  • Jonathan Sobocinski
  • Luca Bertoglio
  • Barend Mees
  • Mauro Gargiulo
  • Nuno Dias
  • Andres Schanzer
  • Warren Gasper
  • Adam W Beck
  • Mark A Farber
  • Kevin Mani
  • Carlos Timaran
  • Darren B Schneider
  • Luis Mendes Pedro
  • Nikolaos Tsilimparis
  • Stéphan Haulon
  • Matthew P Sweet
  • Emília Ferreira
  • Matthew Eagleton
  • Kak Khee Yeung
  • Manar Khashram
  • Katarzyna Jama
  • Giuseppe Panuccio
  • Fiona Rohlffs
  • Thomas Mesnard
  • Roberto Chiesa
  • Andrea Kahlberg
  • Geert Willem Schurink
  • Charlotte Lemmens
  • Enrico Gallitto
  • Gianluca Faggioli
  • Angelos Karelis
  • Ezequiel Parodi
  • Vivian Gomes
  • Anders Wanhainen
  • Mohammed Habib
  • Jesus Porras Colon
  • Felipe Pavarino
  • Mirza S Baig
  • Ryan Eduardo Costeloe De Gouveia E Melo
  • Sean Crawford
  • Sara L Zettervall
  • Rita Garcia
  • Tiago Ribeiro
  • Gonçalo Alves
  • Frederico Bastos Gonçalves
  • Kaj Olav Kappe
  • Samira Elize Mariko van Knippenberg
  • Bich Lan Tran
  • Sinead Gormley
  • Gustavo S Oderich
  • International Multicenter Aortic Research Group

Abstract

OBJECTIVE: To describe outcomes after elective and non-elective fenestrated-branched endovascular aortic repair (FB-EVAR) for thoracoabdominal aortic aneurysms (TAAAs).

BACKGROUND: FB-EVAR has been increasingly utilized to treat TAAAs; however, outcomes after non-elective versus elective repair are not well described.

METHODS: Clinical data of consecutive patients undergoing FB-EVAR for TAAAs at 24 centers (2006-2021) were reviewed. Endpoints including early mortality and major adverse events (MAEs), all-cause mortality, and aortic-related mortality (ARM), were analyzed and compared in patients who had non-elective versus elective repair.

RESULTS: A total of 2603 patients (69% males; mean age 72±10 year old) underwent FB-EVAR for TAAAs. Elective repair was performed in 2187 patients (84%) and non-elective repair in 416 patients [16%; 268 (64%) symptomatic, 148 (36%) ruptured]. Non-elective FB-EVAR was associated with higher early mortality (17% vs 5%, P <0.001) and rates of MAEs (34% vs 20%, P <0.001). Median follow-up was 15 months (interquartile range, 7-37 months). Survival and cumulative incidence of ARM at 3 years were both lower for non-elective versus elective patients (50±4% vs 70±1% and 21±3% vs 7±1%, P <0.001). On multivariable analysis, non-elective repair was associated with increased risk of all-cause mortality (hazard ratio, 1.92; 95% CI] 1.50-2.44; P <0.001) and ARM (hazard ratio, 2.43; 95% CI, 1.63-3.62; P <0.001).

CONCLUSIONS: Non-elective FB-EVAR of symptomatic or ruptured TAAAs is feasible, but carries higher incidence of early MAEs and increased all-cause mortality and ARM than elective repair. Long-term follow-up is warranted to justify the treatment.

Bibliografische Daten

OriginalspracheEnglisch
ISSN0003-4932
DOIs
StatusVeröffentlicht - 01.10.2023

Anmerkungen des Dekanats

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

PubMed 37395613